Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Benign Prostatic Hyperplasia Treatment Device Market Research Report 2021

  • QYR630468
  • 134 Pages
  • July 2016
  • Medical Devices
Download Sample    Get Discount   
 
This report studies Benign Prostatic Hyperplasia Treatment Device in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering

Bard

Dakang Medical

Visit Medical

General Electric Co.

Siemens AG

Medtronic Inc.

Baxter International Inc.

Covidien plc

Novartis AG

Cardinal Health Inc.

Boston Scientific Corp.

Toshiba Corp.

Market Segment by Regions, this report splits Global into several key Region, with production, consumption, revenue, market share and growth rate of Benign Prostatic Hyperplasia Treatment Device in these regions, from 2011 to 2021 (forecast), like

North America

China

Europe

Japan

India

Southeast Asia

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by application, this report focuses on consumption, market share and growth rate of Benign Prostatic Hyperplasia Treatment Device in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

Global Benign Prostatic Hyperplasia Treatment Device Market Research Report 2021

1 Benign Prostatic Hyperplasia Treatment Device Overview

1.1 Product Overview and Scope of Benign Prostatic Hyperplasia Treatment Device

1.2 Benign Prostatic Hyperplasia Treatment Device Segment by Types

1.2.1 Global Production Market Share of Benign Prostatic Hyperplasia Treatment Device by Type in 2015

1.2.2 Type I Overview and Price

1.2.2.1 Type I Overview

1.2.2.2 Type I Price List in 2015 and 2016

1.2.3 Type II

1.2.3.1 Type I Overview

1.2.3.2 Type I Price List in 2015 and 2016

1.2.4 Type III

1.2.4.1 Type I Overview

1.2.4.2 Type I Price List in 2015 and 2016

1.3 Benign Prostatic Hyperplasia Treatment Device Segment by Application

1.3.1 Benign Prostatic Hyperplasia Treatment Device Consumption Market Share by Application in 2015

1.3.2 Application 1 and Major Clients (Buyers) List

1.3.3 Application 2 and Major Clients (Buyers) List

1.3.4 Application 3 and Major Clients (Buyers) List

1.4 Benign Prostatic Hyperplasia Treatment Device Market by Region

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 China Status and Prospect (2011-2021)

1.4.3 Europe Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 India Status and Prospect (2011-2021)

1.4.6 Southeast Asia Status and Prospect (2011-2021)

1.5 Global Market Size (Value and Volume) of Benign Prostatic Hyperplasia Treatment Device (2011-2021)

1.5.1 Global Benign Prostatic Hyperplasia Treatment Device Sales and Revenue (2011-2021)

1.5.2 Global Benign Prostatic Hyperplasia Treatment Device Sales and Growth Rate (2011-2021)

1.5.3 Global Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)

2 Global Benign Prostatic Hyperplasia Treatment Device Market Competition by Manufacturers

2.1 Global Benign Prostatic Hyperplasia Treatment Device Production and Share by Manufacturers (2015 and 2016)

2.2 Global Benign Prostatic Hyperplasia Treatment Device Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global Benign Prostatic Hyperplasia Treatment Device Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Benign Prostatic Hyperplasia Treatment Device Manufacturing Base Distribution and Product Type

2.5 Competitive Situation and Trends

2.5.1 Expansions

2.5.2 New Product Launches

2.5.3 Acquisitions

2.5.4 Other Developments

3 Global Benign Prostatic Hyperplasia Treatment Device Analysis by Region

3.1 Global Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Market Share by Region (2011-2021)

3.1.1 Global Benign Prostatic Hyperplasia Treatment Device Production Market Share by Region (2011-2021)

3.1.2 Global Benign Prostatic Hyperplasia Treatment Device Revenue Market Share by Region (2011-2021)

3.2 Global Benign Prostatic Hyperplasia Treatment Device Consumption by Region (2011-2021)

3.3 North America

3.3.1 North America Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Price (2011-2021)

3.3.2 North America Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Growth Rate (2011-2021)

3.4 Europe

3.4.1 Europe Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Price (2011-2021)

3.4.2 Europe Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Growth Rate (2011-2021)

3.5 China

3.5.1 China Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Price (2011-2021)

3.5.2 China Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Growth Rate (2011-2021)

3.6 Japan

3.6.1 Japan Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Price (2011-2021)

3.6.2 Japan Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Growth Rate (2011-2021)

3.7 India

3.7.1 India Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Price (2011-2021)

3.7.2 India Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Growth Rate (2011-2021)

3.8 Southeast Asia

3.8.1 Southeast Asia Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Price (2011-2021)

3.8.2 Southeast Asia Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Growth Rate (2011-2021)

4 Global Benign Prostatic Hyperplasia Treatment Device Analysis by Type

4.1 Global Benign Prostatic Hyperplasia Treatment Device Production, Revenue, Market Share and Growth Rate by Type (2011-2021)

4.1.1 Global Benign Prostatic Hyperplasia Treatment Device Production and Market Share by Type (2011-2021)

4.1.2 Global Benign Prostatic Hyperplasia Treatment Device Revenue, Market Share and Growth Rate by Type (2011-2021)

4.2 Type I Production, Revenue, Price and Growth (2011-2021)

4.3 Type II Production, Revenue, Price and Growth (2011-2021)

4.4 Type III Production, Revenue, Price and Growth (2011-2021)

5 Global Benign Prostatic Hyperplasia Treatment Device Market Analysis by Application

5.1 Global Benign Prostatic Hyperplasia Treatment Device Consumption and Market Share by Application (2011-2021)

5.2 Major Regions Benign Prostatic Hyperplasia Treatment Device Consumption by Application in 2015 and 2016

5.2.1 North America Benign Prostatic Hyperplasia Treatment Device Consumption by Application

5.2.2 Europe Benign Prostatic Hyperplasia Treatment Device Consumption by Application

5.2.3 China Benign Prostatic Hyperplasia Treatment Device Consumption by Application

5.2.4 Japan Benign Prostatic Hyperplasia Treatment Device Consumption by Application

5.2.5 India Benign Prostatic Hyperplasia Treatment Device Consumption by Application

5.2.6 Southeast Asia Benign Prostatic Hyperplasia Treatment Device Consumption by Application

5.3 Global Benign Prostatic Hyperplasia Treatment Device Consumption Growth Rate by Application (2011-2021)

5.4 Market Drivers and Opportunities

5.4.1 Potential Applications

5.4.2 Emerging Markets/Countries

6 Global Benign Prostatic Hyperplasia Treatment Device Manufacturers Analysis

6.1 Bard

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology

6.1.2.1 Type I

6.1.2.2 Type II

6.1.2.3 Type III

6.1.3 Medical Devices Production, Revenue, Price of Benign Prostatic Hyperplasia Treatment Device (2015 and 2016)

6.2 Dakang Medical

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology

6.2.2.1 Type I

6.2.2.2 Type II

6.2.2.3 Type III

6.2.3 Dakang Medical Production, Revenue, Price of Benign Prostatic Hyperplasia Treatment Device (2015 and 2016)

6.3 Visit Medical

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology

6.3.2.1 Type I

6.3.2.2 Type II

6.3.2.3 Type III

6.3.3 Visit Medical Production, Revenue, Price of Benign Prostatic Hyperplasia Treatment Device (2015 and 2016)

6.4 General Electric Co.

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology

6.4.2.1 Type I

6.4.2.2 Type II

6.4.3 General Electric Co. Production, Revenue, Price of Benign Prostatic Hyperplasia Treatment Device (2015 and 2016)

6.5 Siemens AG

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology

6.5.2.1 Type I

6.5.2.2 Type II

6.5.3 Siemens AG Production, Revenue, Price of Benign Prostatic Hyperplasia Treatment Device (2015 and 2016)

6.6 Medtronic Inc.

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology

6.6.2.1 Type I

6.6.2.2 Type II

6.6.3 Medtronic Inc. Production, Revenue, Price of Benign Prostatic Hyperplasia Treatment Device (2015 and 2016)

6.7 Baxter International Inc.

6.7.1 Company Basic Information, Manufacturing Base and Competitors

6.7.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology

6.7.2.1 Type I

6.7.2.2 Type II

6.7.3 Baxter International Inc. Production, Revenue, Price of Benign Prostatic Hyperplasia Treatment Device (2015 and 2016)

6.8 Covidien plc

6.8.1 Company Basic Information, Manufacturing Base and Competitors

6.8.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology

6.8.2.1 Type I

6.8.2.2 Type II

6.8.3 Covidien plc Production, Revenue, Price of Benign Prostatic Hyperplasia Treatment Device (2015 and 2016)

6.9 Novartis AG

6.9.1 Company Basic Information, Manufacturing Base and Competitors

6.9.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology

6.9.2.1 Type I

6.9.2.2 Type II

6.9.3 Novartis AG Production, Revenue, Price of Benign Prostatic Hyperplasia Treatment Device (2015 and 2016)

6.10 Cardinal Health Inc.

6.10.1 Company Basic Information, Manufacturing Base and Competitors

6.10.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology

6.10.2.1 Type I

6.10.2.2 Type II

6.10.3 Cardinal Health Inc. Production, Revenue, Price of Benign Prostatic Hyperplasia Treatment Device (2015 and 2016)

6.11 Boston Scientific Corp.

6.12 Toshiba Corp.

7 Benign Prostatic Hyperplasia Treatment Device Technology and Development Trend

7.1 Benign Prostatic Hyperplasia Treatment Device Technology Analysis

7.2 Benign Prostatic Hyperplasia Treatment Device Technology Development Trend

8 Research Findings and Conclusion

List Of Tables and Figures

Figure Picture of Benign Prostatic Hyperplasia Treatment Device

Figure Global Production Market Share of Benign Prostatic Hyperplasia Treatment Device by Type in 2015

Table Benign Prostatic Hyperplasia Treatment Device Product Types of by Manufacturers

Figure Product Picture of Type I

Table Type I Price List in 2015 and 2016

Figure Product Picture of Type II

Table Type II Price List in 2015 and 2016

Figure Product Picture of Type III

Table Type III Price List in 2015 and 2016

Table Benign Prostatic Hyperplasia Treatment Device Consumption Market Share by Applications in 2015 and 2016

Table Benign Prostatic Hyperplasia Treatment Device Major Clients (Buyers) List in Application 1

Table Benign Prostatic Hyperplasia Treatment Device Major Clients (Buyers) List in Application 2

Table Benign Prostatic Hyperplasia Treatment Device Major Clients (Buyers) List in Application 3

Figure North America Benign Prostatic Hyperplasia Treatment Device Production and Growth Rate (2011-2021)

Figure North America Benign Prostatic Hyperplasia Treatment Device Consumption and Growth Rate (2011-2021)

Figure China Benign Prostatic Hyperplasia Treatment Device Production and Growth Rate (2011-2021)

Figure China Benign Prostatic Hyperplasia Treatment Device Consumption and Growth Rate (2011-2021)

Figure Europe Benign Prostatic Hyperplasia Treatment Device Production and Growth Rate (2011-2021)

Figure Europe Benign Prostatic Hyperplasia Treatment Device Consumption and Growth Rate (2011-2021)

Figure Japan Benign Prostatic Hyperplasia Treatment Device Production and Growth Rate (2011-2021)

Figure Japan Benign Prostatic Hyperplasia Treatment Device Consumption and Growth Rate (2011-2021)

Figure India Benign Prostatic Hyperplasia Treatment Device Production and Growth Rate (2011-2021)

Figure India Benign Prostatic Hyperplasia Treatment Device Consumption and Growth Rate (2011-2021)

Figure Southeast Asia Benign Prostatic Hyperplasia Treatment Device Production and Growth Rate (2011-2021)

Figure Southeast Asia Benign Prostatic Hyperplasia Treatment Device Consumption and Growth Rate (2011-2021)

Table Global Benign Prostatic Hyperplasia Treatment Device Production and Revenue (2011-2021)

Figure Global Benign Prostatic Hyperplasia Treatment Device Production and Growth Rate (2011-2021)

Figure Global Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)

Table Global Benign Prostatic Hyperplasia Treatment Device Production of Key Manufacturers (2015 and 2016)

Table Global Benign Prostatic Hyperplasia Treatment Device Production Share by Manufacturers (2015 and 2016)

Figure 2015 Benign Prostatic Hyperplasia Treatment Device Production Share by Manufacturers

Figure 2016 Benign Prostatic Hyperplasia Treatment Device Production Share by Manufacturers

Table Global Benign Prostatic Hyperplasia Treatment Device Revenue by Manufacturers (2015 and 2016)

Table Global Benign Prostatic Hyperplasia Treatment Device Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Benign Prostatic Hyperplasia Treatment Device Revenue Share by Manufacturers

Table 2016 Global Benign Prostatic Hyperplasia Treatment Device Revenue Share by Manufacturers

Table Global Market Benign Prostatic Hyperplasia Treatment Device Average Price of Key Manufacturers (2015 and 2016)

Table Manufacturers Benign Prostatic Hyperplasia Treatment Device Manufacturing Base Distribution and Product Type

Table Global Benign Prostatic Hyperplasia Treatment Device Production Market by Region (2011-2021)

Figure Global Benign Prostatic Hyperplasia Treatment Device Production Market by Region (2011-2021)

Figure Global Benign Prostatic Hyperplasia Treatment Device Production Market Share by Region (2011-2021)

Table Global Benign Prostatic Hyperplasia Treatment Device Revenue Market by Region (2011-2021)

Table Global Benign Prostatic Hyperplasia Treatment Device Revenue Market Share by Region (2011-2021)

Table Global Benign Prostatic Hyperplasia Treatment Device Consumption Market by Region (2011-2021)

Table Global Benign Prostatic Hyperplasia Treatment Device Consumption Market Share by Region (2011-2021)

Figure Global Benign Prostatic Hyperplasia Treatment Device Consumption Market Share by Region (2011-2021)

Table North America Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Price (2011-2021)

Figure North America Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Growth Rate (2011-2021)

Table Europe Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Price (2011-2021)

Figure Europe Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Growth Rate (2011-2021)

Table China Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Price (2011-2021)

Figure China Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Growth Rate (2011-2021)

Table Japan Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Price (2011-2021)

Figure Japan Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Growth Rate (2011-2021)

Table India Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Price (2011-2021)

Figure India Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Growth Rate (2011-2021)

Table Southeast Asia Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Price (2011-2021)

Figure Southeast Asia Benign Prostatic Hyperplasia Treatment Device Production, Revenue and Growth Rate (2011-2021)

Table Global Benign Prostatic Hyperplasia Treatment Device Production by Type (2011-2021)

Table Global Benign Prostatic Hyperplasia Treatment Device Production Share by Type (2011-2021)

Figure Production Market Share of Benign Prostatic Hyperplasia Treatment Device by Type (2011-2021)

Figure Global Benign Prostatic Hyperplasia Treatment Device Production Growth Rate by Type (2011-2021)

Table Global Benign Prostatic Hyperplasia Treatment Device Revenue by Type (2011-2021)

Table Global Benign Prostatic Hyperplasia Treatment Device Revenue Share by Type (2011-2021)

Figure Global Benign Prostatic Hyperplasia Treatment Device Revenue Growth Rate by Type (2011-2021)

Figure Type I Production, Revenue and Growth (2011-2021)

Figure Type I Price Trend (2011-2021)

Figure Type II Production, Revenue and Growth (2011-2021)

Figure Type II Price Trend (2011-2021)

Figure Type III Production, Revenue and Growth (2011-2021)

Figure Type III Price Trend (2011-2021)

Table Global Benign Prostatic Hyperplasia Treatment Device Consumption by Application (2011-2021)

Table Global Benign Prostatic Hyperplasia Treatment Device Consumption Market Share by Application (2011-2021)

Figure Global Benign Prostatic Hyperplasia Treatment Device Consumption Market Share by Application in 2015

Figure Global Benign Prostatic Hyperplasia Treatment Device Consumption Market Share by Application in 2021

Table North America Benign Prostatic Hyperplasia Treatment Device Consumption by Application (2015 and 2016)

Table Europe Benign Prostatic Hyperplasia Treatment Device Consumption by Application (2015 and 2016)

Table China Benign Prostatic Hyperplasia Treatment Device Consumption by Application (2015 and 2016)

Table Japan Benign Prostatic Hyperplasia Treatment Device Consumption by Application (2015 and 2016)

Table India Benign Prostatic Hyperplasia Treatment Device Consumption by Application (2015 and 2016)

Table Southeast Asia Benign Prostatic Hyperplasia Treatment Device Consumption by Application (2015 and 2016)

Table Global Benign Prostatic Hyperplasia Treatment Device Consumption Growth Rate by Application (2011-2021)

Figure Global Benign Prostatic Hyperplasia Treatment Device Consumption Growth Rate by Application (2011-2021)

Table Bard Basic Information List

Table Benign Prostatic Hyperplasia Treatment Device Production, Revenue, Price of Bard (2015 and 2016)

Table Dakang Medical Basic Information List

Table Benign Prostatic Hyperplasia Treatment Device Production, Revenue, Price of Dakang Medical (2015 and 2016)

Table Visit Medical Basic Information List

Table Benign Prostatic Hyperplasia Treatment Device Production, Revenue, Price of Visit Medical (2015 and 2016)

Table General Electric Co. Basic Information List

Table Benign Prostatic Hyperplasia Treatment Device Production, Revenue, Price of General Electric Co. (2015 and 2016)

Table Siemens AG Basic Information List

Table Benign Prostatic Hyperplasia Treatment Device Production, Revenue, Price of Siemens AG (2015 and 2016)

Table Medtronic Inc. Basic Information List

Table Benign Prostatic Hyperplasia Treatment Device Production, Revenue, Price of Medtronic Inc. (2015 and 2016)

Table Baxter International Inc. Basic Information List

Table Benign Prostatic Hyperplasia Treatment Device Production, Revenue, Price of Baxter International Inc. (2015 and 2016)

Table Covidien plc Basic Information List

Table Benign Prostatic Hyperplasia Treatment Device Production, Revenue, Price of Covidien plc (2015 and 2016)

Table Novartis AG Basic Information List

Table Benign Prostatic Hyperplasia Treatment Device Production, Revenue, Price of Novartis AG (2015 and 2016)

Table Cardinal Health Inc. Basic Information List

Table Benign Prostatic Hyperplasia Treatment Device Production, Revenue, Price of Cardinal Health Inc. (2015 and 2016)

Table Boston Scientific Corp. Basic Information List

Table Benign Prostatic Hyperplasia Treatment Device Production, Revenue, Price of Boston Scientific Corp. (2015 and 2016)

Table Toshiba Corp. Basic Information List

Table Benign Prostatic Hyperplasia Treatment Device Production, Revenue, Price of Toshiba Corp. (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370